Ausgabe 4/2019
Inhalt (19 Artikel)
Optimizing care for geriatric cancer patients: the greatest challenge in medical oncology?
Rupert Bartsch
Prevalence of comorbidity in cancer patients scheduled for systemic anticancer treatment in Austria
Marija Balic, Wolfgang Hilbe, Sylvia Gusel, Michael Fiegl, Heinz Ludwig, Beate Mayrbäurl, Josef Thaler, Hellmut Samonigg, Karin Hegenbarth, Florian Eisner, Brigitte Mlineritsch, Richard Greil, Maria Johanna Schandl, Ansgar Weltermann, Andreas Petzer, David Fuchs, Wolfgang Stangl, Peter Krippl, Reinhard Stauder, Herbert Stöger
Targeted therapy in lung cancer—ASCO 2019 update
Romana E. Wass, David Lang, Bernd Lamprecht, Michael Studnicka
ASCO 2019: highlights in HER2-positive metastatic breast cancer
Rupert Bartsch, Elisabeth Bergen
Adjuvant breast cancer: (neo)adjuvant therapy for HER2-positive breast cancer
Christoph Suppan, Marija Balic
Management of nonmetastatic muscle invasive bladder cancer in the elderly
Stephan Madersbacher
Nonmuscle invasive urothelial cancer— Bacillus Calmette–Guérin instillation or checkpoint inhibitor immunotherapy?
Stephan Brönimann, Shahrokh F. Shariat, Melanie R. Hassler
Advanced/metastatic urothelial carcinoma of the bladder and upper urinary tract
Georg C. Hutterer, Martin Pichler
Neoadjuvant therapy in urothelial cancer
Stephan Brönimann, David D’Andrea, Shahrokh F. Shariat, Kilian M. Gust
First-line treatment of metastatic renal cell carcinoma: current standard of care
Martin Marszalek
Second-line therapy in metastatic renal cell cancer—how do we treat after immuno-oncology drugs?
Ursula Vogl
Surgery in renal cell carcinoma—when, whom and how?
Sebastian Lenart, Ingrid Berger, Nikolaus Hartig, Stephan Madersbacher, Anton Ponholzer
Giant leiomyoma of the renal capsule: CT and MR imaging features with pathologic correlations
Arnaldo Stanzione, Michele Santangelo, Filippo De Rosa, Andrea Ponsiglione, Gaia Peluso, Luigi Insabato, Massimo Imbriaco